- Home
- ACVA vs APLS Comparison
ACVA vs APLS Comparison
Compare ACVA & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACVA
- APLS
- Stock Information
- Founded
- ACVA 2014
- APLS 2009
- Country
- ACVA United States
- APLS United States
- Employees
- ACVA N/A
- APLS N/A
- Industry
- ACVA Business Services
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ACVA Consumer Discretionary
- APLS Health Care
- Exchange
- ACVA Nasdaq
- APLS Nasdaq
- Market Cap
- ACVA 3.4B
- APLS 4.0B
- IPO Year
- ACVA 2021
- APLS 2017
- Fundamental
- Price
- ACVA $21.53
- APLS $29.94
- Analyst Decision
- ACVA Strong Buy
- APLS Buy
- Analyst Count
- ACVA 9
- APLS 18
- Target Price
- ACVA $24.22
- APLS $46.59
- AVG Volume (30 Days)
- ACVA 1.3M
- APLS 2.1M
- Earning Date
- ACVA 02-19-2025
- APLS 02-25-2025
- Dividend Yield
- ACVA N/A
- APLS N/A
- EPS Growth
- ACVA N/A
- APLS N/A
- EPS
- ACVA N/A
- APLS N/A
- Revenue
- ACVA $596,019,000.00
- APLS $715,216,000.00
- Revenue This Year
- ACVA $34.25
- APLS $95.82
- Revenue Next Year
- ACVA $24.47
- APLS $12.02
- P/E Ratio
- ACVA N/A
- APLS N/A
- Revenue Growth
- ACVA 29.34
- APLS 162.10
- 52 Week Low
- ACVA $12.84
- APLS $24.34
- 52 Week High
- ACVA $23.46
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- ACVA 53.30
- APLS 43.96
- Support Level
- ACVA $19.93
- APLS $27.61
- Resistance Level
- ACVA $22.00
- APLS $30.13
- Average True Range (ATR)
- ACVA 0.83
- APLS 1.48
- MACD
- ACVA 0.01
- APLS -0.46
- Stochastic Oscillator
- ACVA 71.43
- APLS 31.45
About ACVA ACV Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.